Compare AVTX & MNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
Manitex International Inc through its subsidiaries is engaged in the design, manufacture, and distribution of engineered lifting solutions. Its products include boom trucks, truck cranes, and sign cranes. The company's segments include Lifting Equipment and Rental Equipment. It generates maximum revenue from the Lifting Equipment segment. Geographically, it derives majority of its revenue from the United States.